The Technology Strategy Board, in partnership with the Department of Health (DH), is to invest up to £1m in projects to produce new and improved tools, products or capabilities in the field of health economics to assist companies in the design and evaluation of diagnostic clinical trials.
It is envisaged that the new tools will lead to better adoption of new diagnostic products, where appropriate, by providing assessors and decision-makers with high-quality data on their impact. This competition has been developed in discussion with the National Institute for Health and Clinical Excellence (NICE) and the British In Vitro Diagnostics Association (BIVDA).
Registration closing date: 9th of November 2011
Read more on the TSB website.
Follow Life Sciences networks on LinkedIn
GlobalScots, Nexxus, Interface, Centre for Health Science
Follow Life Sciences Scotland on Twitter
Carolyn McTaggart updated an event
Dr Shara Cohen posted events
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual Miniaturisation Event - Micro Scale Bioprocess Development'
Dr Shara Cohen commented on Dr Shara Cohen's event 'Cell suicide is not painless for the flow cytometrist: new assays to measure cell death'
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Improving Immunohistochemistry Discussion Forum'
Dr Shara Cohen is attending Adaora Okechuku's event
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine"'
© 2012 Created by Siobhan McDermit.
Powered by
You need to be a member of Life Sciences Scotland to add comments!
Join Life Sciences Scotland